Medicine and Dentistry
Acute Liver Failure
37%
Acute on Chronic Liver Failure
7%
Anti-Inflammatory Drug
7%
Anticoagulant
26%
Antithrombotic
22%
Bleeding
25%
Blood Clotting
7%
Blood Clotting Inhibitor
7%
Blood Product
7%
Blood Stasis
47%
Chronic Liver Disease
8%
Consultation
29%
Dabigatran
7%
Disease
10%
Euglobulin Lysis Test
41%
Fibrinogen
15%
Fibrinolysis
67%
Fibrosis
29%
Hemostat
78%
Hepatic Portal Vein
49%
Hepatic Vein
22%
Hepatobiliary Surgery
14%
Hypocoagulability
7%
Ischemia
7%
Laboratory Test
7%
Liver Cirrhosis
100%
Liver Disease
59%
Liver Injury
7%
Liver Transplantation
7%
Multiple Organ Dysfunction Syndrome
7%
Observational Study
29%
Outpatient
29%
Partial Thromboplastin Time
7%
Platelet
14%
Portal Hypertension
14%
Portal Vein Blood Flow
9%
Portal Vein Thrombosis
93%
Procoagulant
7%
Prospective Cohort Study
29%
Prospective Study
29%
Prothrombin Time
7%
Rivaroxaban
7%
Systemic Circulation
17%
Thrombin
14%
Thrombocyte Release Reaction
7%
Thromboplastin
7%
Thrombus
32%
Tissue Plasminogen Activator
14%
Von Willebrand Factor
60%
Von Willebrand Factor Cleaving Proteinase
29%
Keyphrases
Acute Liver Failure
29%
Acute Liver Injury
7%
ADAMTS13
29%
Advanced Liver Disease
29%
Anticoagulant Pathways
9%
Bleeding
32%
Bleeding Patients
7%
Chronic Liver Disease
8%
Cirrhosis
32%
Clot Lysis
11%
Coagulation
35%
Consultation Duration
7%
Control Preferences Scale
7%
Decision-making Behavior
44%
Decision-making Process
43%
Decision-making Styles
29%
Factor Level
14%
Family Members
29%
Fibrinolysis
29%
Hemostasis
12%
Hepatic Vein
19%
Hospital Consultants
29%
Hospital Outpatient Clinics
7%
Hypercoagulability
33%
Hypofibrinolysis
7%
Inflammation
8%
Ischemia Progression
9%
Liquid Permeation
11%
Liver
9%
Multilevel Analysis
7%
Netherlands
7%
Non-tumoral Portal Vein Thrombosis
11%
Older Patients
29%
Opening Statement
29%
Participatory Decision-making
29%
Patient Participation
14%
Patients with Liver Disease
8%
Portal Thrombosis
29%
Portal Vein
44%
Portal Vein Thrombosis
33%
Portal Vein Thrombus
29%
Prospective Cohort Study
29%
Secondary Care
7%
Sectional Analysis
7%
Shared Decision Making
52%
Systemic Circulation
15%
Teaching Hospital
7%
Thrombin Generation
11%
Vascular Bed
29%
Von Willebrand Factor
36%
Pharmacology, Toxicology and Pharmaceutical Science
Acute Liver Failure
37%
Acute on Chronic Liver Failure
7%
Anti-Inflammatory Drug
7%
Anticoagulant Agent
44%
Bleeding
22%
Blood Clotting Inhibitor
7%
Blood Stasis
33%
Clotting Time
9%
Dabigatran
9%
Disease
7%
Enoxaparin
9%
Fibrinogen
7%
Fibrinolytic Agent
29%
Hemostatic Agent
18%
Hypocoagulability
7%
Inflammation
33%
Ischemia
7%
Liver Cirrhosis
7%
Liver Disease
29%
Liver Injury
7%
Multiple Organ Failure
7%
Procoagulant
7%
Prothrombin
7%
Rivaroxaban
9%
Thrombin
14%
Thromboplastin
14%
Tissue Plasminogen Activator
19%
Von Willebrand Factor
44%
Von Willebrand Factor Cleaving Proteinase
29%
